Hyundai pharm - stock earnings
004310.KS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 6.1 billion KRW | 180.8 billion KRW |
| 2022 | -164.6 million KRW | 162.7 billion KRW |
| 2021 | -3.2 billion KRW | 139.8 billion KRW |
| 2020 | 2.2 billion KRW | 133.0 billion KRW |
| 2019 | 1.2 billion KRW | 134.9 billion KRW |
| 2018 | 928.9 million KRW | 133.9 billion KRW |
| 2017 | 1.5 billion KRW | 130.5 billion KRW |
| 2016 | 1.3 billion KRW | 120.0 billion KRW |
| 2013 | 1.4 billion KRW | 108.1 billion KRW |
| 2012 | -4.8 billion KRW | 102.3 billion KRW |
| 2011 | 520.1 million KRW | 114.3 billion KRW |
| 2010 | 3.0 billion KRW | 111.9 billion KRW |
004310.KS
Price: ₩3,780
52 week price:
Dividend Yield: 0.89%
Exchange: KSC
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 101.5 billion
Average Dividend Frequency: 1